Literature DB >> 14664792

Adeno-associated virus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor reduces atherosclerotic lesion formation in LDL receptor knockout mice.

Johanna Jalkanen1, Pia Leppänen, Katri Pajusola, Outi Närvänen, Anssi Mähönen, Elisa Vähäkangas, David R Greaves, Hansruedi Büeler, Seppo Ylä-Herttuala.   

Abstract

Macrophage scavenger receptors (MSR) promote atherosclerotic lesion formation, and modulation of MSR activity has been shown to influence atherosclerosis. Soluble receptors are effective in inhibiting receptor-mediated functions in various diseases. We have generated a secreted macrophage scavenger receptor (sMSR) that consists of the bovine growth hormone signal sequence and the human MSR A I extracellular domains. sMSR reduces degradation of atherogenic modified low-density lipoproteins and monocyte/macrophage adhesion on endothelial cells in vitro. To test long-term effects of sMSR, atherosclerosis-susceptible LDLR knockout mice were transduced via the tail vein with an adeno-associated virus (AAV) expressing sMSR or control enhanced green fluorescent protein (EGFP), and a Western-type diet was started. Gene transfer caused a temporary elevation in alkaline phosphatase and aspartate amino transferase values without a change in C-reactive protein. sMSR protein was detected in the plasma of the transduced mice by a specific ELISA 6 months after the gene transfer. AAV-mediated sMSR gene transfer reduced atherosclerotic lesion area in the aorta by 21% (P < 0.05) compared to EGFP-transduced control mice. Even though eradication of established disease was not possible, atherosclerotic lesion formation could be modified using AAV-mediated gene transfer of the decoy sMSR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14664792     DOI: 10.1016/j.ymthe.2003.09.012

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  8 in total

Review 1.  Liver-directed gene therapy for dyslipidemia and diabetes.

Authors:  Kazuhiro Oka; Lawrence Chan
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

2.  Induced pluripotent stem cell clones reprogrammed via recombinant adeno-associated virus-mediated transduction contain integrated vector sequences.

Authors:  J Weltner; A Anisimov; K Alitalo; T Otonkoski; R Trokovic
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 3.  AAV-mediated gene therapy for atherosclerosis.

Authors:  Michael Lehrke; Corinna Lebherz
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

4.  GDF11 Protects against Endothelial Injury and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Null Mice.

Authors:  Wen Mei; Guangda Xiang; Yixiang Li; Huan Li; Lingwei Xiang; Junyan Lu; Lin Xiang; Jing Dong; Min Liu
Journal:  Mol Ther       Date:  2016-08-09       Impact factor: 11.454

Review 5.  Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis.

Authors:  Maryam Mahjoubin-Tehran; Yong Teng; Amin Jalili; Seyed Hamid Aghaee-Bakhtiari; Alexander M Markin; Amirhossein Sahebkar
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

6.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

7.  Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B.

Authors:  Ying Chen; Zuxiong Huang; Di Ma; Liqian Chen; Qintao Lai; Xuan Huang; Jia Zhou; Xiaoyong Zhang; Qiang Ma; Zhengliang Chen; Daming Zuo
Journal:  BMC Immunol       Date:  2015-05-16       Impact factor: 3.615

8.  Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia.

Authors:  Agnieszka Jazwa; Mateusz Tomczyk; Hevidar M Taha; Elisa Hytonen; Mateusz Stoszko; Lorena Zentilin; Mauro Giacca; Seppo Yla-Herttuala; Costanza Emanueli; Alicja Jozkowicz; Jozef Dulak
Journal:  Vasc Cell       Date:  2013-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.